comprehensive -WSS

comprehensive

author：hotspot 2025-09-04 04:25:11 - browse：76

Bristol Myers Squibb sign — Courtesy Bristol Myers Squibb

Bristol Myers Squibb said that it would purchase Mirati Therapeutics, maker of the cancer drug Krazati, for $4.8 billion in cash in a deal that shows the continued interest of large pharmaceutical firms in relatively small “bolt-on” acquisitions.

Bristol said that it would pay $58.00 per share for Mirati, and would hold another $12.00 per share, or a total of $1 billion, to be paid if one of two different applications for an additional use for Krazati is approved within seven years after the merger closes.

Chris Boerner, Bristol’s chief operating officer and CEO-elect, said in a statement that Mirati had several cancer drugs in development that could deliver sales in the latter half of the decade and beyond, when investors worry that Bristol will need new products to sustain its growth.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： How artificial intelligence is being used to detect, treat cancer

explore

Wikipedia

WSS

Artificial intelligence advances fuel industry trying to preserve loved ones after death

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

What’s missing from the debate over nursing home staff minimums

Top private equity targets in 2023: cardiology, clinical trials, lasers

How artificial intelligence is being used to detect, treat cancer

knowledge

comprehensive

focus

Medicare proposal to cover medical devices draws a mixed reaction

Surgery pushed Ben Carson to fame

Jerome Adams on the need for new antivirals for Covid

AstraZeneca stays mum on Medicare drug pricing negotiations

Apple is now the first public company to be valued at $3 trillion

Providers still hesitate to prescribe buprenorphine, study finds

Apple is now the first public company to be valued at $3 trillion

CDC backtracks, saying fully vaccinated people can go maskless indoors

Trump demands the U.S. pay no more for drugs than other countries … again

As Taiwan prepares for anti

focus

New rules on organ donation and transplantation 'will bring chaos'

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Providers still hesitate to prescribe buprenorphine, study finds

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

As Taiwan prepares for anti

AstraZeneca stays mum on Medicare drug pricing negotiations

explore

leisure time

Wikipedia

focus